Anjan Aralihalli

Anjan founded Raya Therapeutic which is focused on developing multiple drugs to treat ALS and other neurodegenerative diseases. Prior to Raya, Anjan worked at a variety of biotechs, pharmas and as a venture partner. He has 25+ years of international experience across several functions including investor relations, corporate development, venture and angel financing, in & out-licensing, sales, marketing, & clinical trial management. He is also on the board of the Muscular Dystrophy Association in the United States.